Stay updated with breaking news from Edward Barger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region Partnership provides access to hospitals in key...
Data to be presented at the 2023 International Society of Neurochemistry (ISN) and the European Society of Neurochemistry (ESN) meeting in Portugal Data provides further evidence that selective neuronal nitric oxide synthase (nNOS) inhibitors can play a role in the treatment of ASD Poster presentation position nitric oxide (NO) as a novel therapeutic target for ASD: Focus on CNTNAP2-/- mouse model GARDEN CITY, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air”
22.06.2023 - Successfully completed phase 1 of U.S. commercial launch, with multiple hospitals contracted, and have initiated phase 2 of launch for LungFit PH for the treatment of term and near-term neonates with hypoxic respiratory failure Presented positive ...
GARDEN CITY, N.Y., May 16, 2023 -- Beyond Air, Inc. , a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide for the treatment of patients with... | May 16, 2023
09.02.2023 - U.S. commercial launch continues for LungFit PH for the treatment of term and near-term neonates with hypoxic respiratory failure Presented positive in vivo combination data with anti-PD1 that support the potential of the Company’s novel gaseous ...